| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.983 | 8 | 0 | 1992 | 2019 | ||||||||
|
suppressor of cytokine signaling 1 | 0.445 | 0.808 | 0.59 |
|
group | 0.360 | None | 1.000 | 3 | 0 | 2005 | 2019 | ||||||||
|
forkhead box P1 | 0.460 | 0.808 | 1.00 |
|
group | 0.200 | None | 1.000 | 5 | 0 | 2005 | 2018 | ||||||||
|
MALT1 paracaspase | 0.532 | 0.769 | 0.99 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 2000 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.200 | None | 1.000 | 2 | 0 | 1988 | 2020 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 1992 | 2019 | |||||||||
|
BCL10 immune signaling adaptor | 0.491 | 0.769 | 0.34 |
|
group | 0.200 | None | 0.955 | 1 | 0 | 1999 | 2018 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 1997 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.190 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
baculoviral IAP repeat containing 3 | 0.491 | 0.769 | 6.6E-02 |
|
group | 0.170 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
BCL6 transcription repressor | 0.444 | 0.808 | 0.96 |
|
group | 0.100 | None | 0.972 | 17 | 0 | 1993 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.100 | None | 0.989 | 9 | 0 | 1988 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.983 | 7 | 0 | 1983 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.977 | 4 | 0 | 2000 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.100 | None | 0.960 | 3 | 0 | 1992 | 2019 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
group | 0.100 | None | 0.996 | 3 | 0 | 1998 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.100 | None | 1.000 | 3 | 0 | 1995 | 2019 | ||||||||
|
PR/SET domain 1 | 0.538 | 0.731 | 0.96 |
|
group | 0.100 | None | 1.000 | 3 | 0 | 1996 | 2020 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 2005 | 2018 | ||||||||
|
REL proto-oncogene, NF-kB subunit | 0.579 | 0.692 | 1.00 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 1996 | 2016 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 2000 | 2019 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 1997 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.100 | None | 0.967 | 1 | 0 | 1990 | 2020 |